SCRI-Denver HealthOne — Denver, Colorado

SCRI-Denver HealthOne is a clinical research site located in Denver, Colorado, United States 37203.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI-Denver HealthOne has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer Stage III, HER2-positive Metastatic Breast Cancer, Unresectable Breast Carcinoma.

Sponsors: SystImmune Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI-Denver HealthOne?

SCRI-Denver HealthOne has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI-Denver HealthOne conducted?

SCRI-Denver HealthOne has 1 clinical trials on record, with 1 currently active. Their work covers Breast Cancer Stage III, HER2-positive Metastatic Breast Cancer, Unresectable Breast Carcinoma.

Is SCRI-Denver HealthOne accredited by Crixeo Health?

SCRI-Denver HealthOne has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI-Denver HealthOne?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.